Results 171 to 180 of about 1,251,661 (316)

Camouflage Treatment of a Severe Open Bite Case

Turkish Journal of Orthodontics, 2014
Alev Yılmaz, Ayça Arman-Özçırpıcı
doaj   +1 more source

Comprehensive genomic analysis reveals the class II diterpene cyclases in Dodonaea viscosa. [PDF]

Phytochemistry
Helwig K, Peters RJ.
europepmc   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

HLA Class II Protein Expression Regulation Is Strongly Linked to Cis-Acting SNPs. [PDF]

HLA
Vince N, Ramsuran V, Viard M, Martinson J, Wolinsky S, Hussain S, Seaberg EC, Brown TT, Spence N, Thio CL, Goedert JJ, Hoots WK, Kirk GD, Carrington M.   +13 more
europepmc   +1 more source

Establishment of a humanized patient‐derived xenograft mouse model of high‐grade serous ovarian cancer for preclinical evaluation of combination immunotherapy

Molecular Oncology, EarlyView.
We have established a humanized orthotopic patient‐derived xenograft (Hu‐oPDX) mouse model of high‐grade serous ovarian cancer (HGSOC) that recapitulates human tumor–immune interactions. Using combined anti‐PD‐L1/anti‐CD73 immunotherapy, we demonstrate the model's improved biological relevance and enhanced translational value for preclinical ...
Luka Tandaric, Line Bjørge, Martine Rott Lode, Cecilie Fredvik Torkildsen, Pia Aehnlich, Rammah Elnour, Daniela Elena Costea, Lars Andreas Akslen, Liv Cecilie Vestrheim Thomsen, Emmet McCormack, Katrin Kleinmanns   +10 more
wiley   +1 more source

Structural basis of odorant recognition by a mammalian class II odorant receptor. [PDF]

Sci Adv
Gil M, Choi C, Kim M, Bae M, Lee H, Choi I, Im W, Choi HJ.   +7 more
europepmc   +1 more source

On some classes of operators, I [PDF]

Proceedings of the Japan Academy, Series A, Mathematical Sciences, 1967
ISTRATESCU, Vasile, ISTRATESCU, Ioana
openaire   +5 more sources

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

Molecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni, Antonella Palmese, Stefano Scalera, Laura Cipriani, Davide Mascolo, Patrizia Vici, Teresa Arcuri, Lorena Filomeno, Eriseld Krasniqi, Giovanni Blandino, Giulia Bon, Marcello Maugeri‐Saccà   +11 more
wiley   +1 more source

Deciphering transcriptional plasticity in pancreatic ductal adenocarcinoma reveals alterations in sensory neuron innervation

Molecular Oncology, EarlyView.
Pancreatic sensory neurons innervating healthy and PDAC tissue were retrogradely labeled and profiled by single‐cell RNA sequencing. Tumor‐associated innervation showed a dominant neurofilament‐positive subtype, altered mitochondrial gene signatures, and reduced non‐peptidergic neurons.
Elena Genova, Michele Montrone, Uday Rangaswamy, Francesco Diversi, Irene Schiavo, Denise Ferrarini, Roberta Di Florio, Irene Longo, Michele Coscia, Nicola Zamboni, Giorgia Demontis, Lisa Veghini, Vincenzo Corbo, Remo Sanges, Paul Heppenstall   +14 more
wiley   +1 more source

BRAF class II-III mutations in NSCLC: a single center experience. [PDF]

Front Oncol
Torresan S, Bortolot M, Bertoli E, Del Conte A, Stanzione B, de Carlo E, Schiappacassi M, Spina M, Baldassarre G, Bearz A.   +9 more
europepmc   +1 more source